welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
In 1994, three of Cindy Parseghian’s four children were diagnosed with Niemann-Pick disease type C (NPC). NPC is a genetic disorder causing an inability in cells to remove cholesterol, resulting in lipid buildup and cell death. Like all three Parseghian children, most children diagnosed do not make it to adulthood.
In 2011, Dakota Fisher-Vance, a pre-med student, received her B.A. in biology and a diagnosis of familial adenomatous polyposis (FAP), which leads to exponential growth of polyps in the colon and eventually cancer. The main treatment is ultimately surgical removal of the colon and other parts of the GI tract.
What do Cindy and Dakota have in common? They’ve stayed positive and committed to building the strongest community they can around these devastating diseases. And new clinical trials in both NPC and FAP offer a ray of hope in bleak situations.
expertly curated content related to this topic
A pharmacokinetic study in healthy volun...
Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Poly...The purpose of this study is to determin...
To test whether celecoxib can be used to...
Eviendep Reduces Number and Size of Duodenal Polyps in Familial Adenomatous Polyposis Patients With Ileal Pouch-Anal...AIM: To evaluate if 3 mo oral supplemen...
Celecoxib and Tauro-Ursodeoxycholic Acid Co-Treatment Inhibits Cell Growth in Familial Adenomatous Polyposis Derived...Chemoprevention would be a desirable str...
Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Pati...This is a registry-based observation...